Milestone Pharmaceuticals Inc. (MIST) stock
MISTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.46+0.05 (+11.42%)
Close on Nov 18, 2026Market cap $57.32MP/E –Yield –
Milestone Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Milestone Pharmaceuticals's free cash flow for the twelve months ending Jun 30, 2026 was -$61.65M. For fiscal 2025 it was -$49.34M. The highest annual figure on record is -$21.05M in fiscal 2018.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$49.34M | – |
| FY2024 | Dec 31, 2024 | -$28.88M | – |
| FY2023 | Dec 31, 2023 | -$46.54M | – |
| FY2022 | Dec 31, 2022 | -$52.74M | – |
| FY2019 | Dec 31, 2019 | -$51.57M | – |
| FY2018 | Dec 31, 2018 | -$21.05M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$22.74M | – |
| Q1 FY2026 | Mar 31, 2026 | -$16.10M | – |
| Q4 FY2025 | Dec 31, 2025 | -$13.06M | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.75M | – |
| Q2 FY2025 | Jun 30, 2025 | -$12.58M | – |
| Q1 FY2025 | Mar 31, 2025 | -$13.96M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.87M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.02M | – |
| Q4 FY2023 | Dec 31, 2023 | -$9.83M | – |
| Q3 FY2023 | Sep 30, 2023 | -$12.18M | – |
| Q2 FY2023 | Jun 30, 2023 | -$10.60M | – |
| Q1 FY2023 | Mar 31, 2023 | -$13.94M | – |
| Q4 FY2022 | Dec 31, 2022 | -$12.97M | – |
| Q3 FY2022 | Sep 30, 2022 | -$11.68M | – |
| Q4 FY2019 | Dec 31, 2019 | -$16.70M | – |
| Q3 FY2019 | Sep 30, 2019 | -$8.59M | – |
| Q4 FY2018 | Dec 31, 2018 | -$7.31M | – |
| Q3 FY2018 | Sep 30, 2018 | -$5.59M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.42M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.73M | – |
See a number that looks wrong?